about
A regenerative approach to the treatment of multiple sclerosis.Multiformat T-cell-engaging bispecific antibodies targeting human breast cancers.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemiaPLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Virginie Tardif
@ast
Virginie Tardif
@en
Virginie Tardif
@es
Virginie Tardif
@nl
type
label
Virginie Tardif
@ast
Virginie Tardif
@en
Virginie Tardif
@es
Virginie Tardif
@nl
prefLabel
Virginie Tardif
@ast
Virginie Tardif
@en
Virginie Tardif
@es
Virginie Tardif
@nl
P108
P106
P108
P1153
26041127600
P21
P31
P496
0000-0001-5604-6524